V beta specificity of superantigen TSST-1 plus CD28 costimulation without APCs.

Little has so far been known about the role of antigen-presenting cells (APCs) in the activation of T cells by superantigens. Recently several studies showed that superantigens could directly activate purified T cells in the presence of CD28 costimulation. Here we investigate V beta expression of T cells activated by the superantigen toxic shock syndrome toxin-1 (TSST-1), plus CD28 costimulation, in the absence of APCs. The aim of this study was to ask if TSST-1 activated purified T cells in the presence of CD28 costimulation with the same specificity as in the presence of APCs. We provide evidence that the specificity of TSST-1 to human V beta, in the presence of CD28 costimulation, is identical to that in the presence of APCs, with V beta 2 being significantly expanded. The results indicate that the main role of APCs in the superantigen-mediated T cell activation may be to provide T cells with CD28 costimulation.

[1]  J. Silver,et al.  Vβ‐Specific Activation of T Cells by the HIV Glycoprotein gp 160 , 1995, Scandinavian journal of immunology.

[2]  C. Riccardi,et al.  Superantigen-induced peripheral T-cell deletion: the effects of chemical modification of antigen-presenting cells, interleukin-4 and glucocorticoid hormones. , 1995, Immunology.

[3]  P. Linsley,et al.  CD28 cross-linking augments TCR-mediated signals and costimulates superantigen responses. , 1995, Journal of immunology.

[4]  R. Klausner,et al.  Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro , 1994, Nature.

[5]  H. Reyburn,et al.  Bimodal distribution of Vβ2+CD4+ T cells in human peripheral blood , 1994 .

[6]  B. Bloom,et al.  Evidence for a superantigen in human tuberculosis. , 1994, Immunity.

[7]  R. O'reilly,et al.  Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation. , 1993, Journal of immunology.

[8]  M. Blackman,et al.  How do T-cell receptors, MHC molecules and superantigens get together? , 1993, Immunology today.

[9]  K. Migita,et al.  The fate of anergic T cells in vivo. , 1993, Journal of immunology.

[10]  P. Linsley,et al.  The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.

[11]  P. Marrack,et al.  Superantigens and their potential role in human disease. , 1993, Advances in immunology.

[12]  C. Thompson,et al.  CD28 and staphylococcal enterotoxins synergize to induce MHC-independent T-cell proliferation. , 1992, Cellular immunology.

[13]  J. Monaco.  Major histocompatibility complex-linked transport proteins and antigen processing , 1992, Immunologic research.

[14]  M. Jenkins,et al.  CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. , 1991, Journal of immunology.

[15]  P. Marrack,et al.  Superantigens: mechanism of T-cell stimulation and role in immune responses. , 1991, Annual review of immunology.

[16]  P. Linsley,et al.  T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Marrack,et al.  The staphylococcal enterotoxins and their relatives. , 1990, Science.

[18]  P. Linsley,et al.  Role of the CD28 receptor in T-cell activation. , 1990, Immunology today.

[19]  S. Raziuddin,et al.  Unique Immunological Behaviour of CD8+ (Suppressor T Cell) Leukaemia Cells , 1987, Scandinavian journal of immunology.

[20]  R. Zubler,et al.  The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells. , 1986, Journal of immunology.

[21]  L. Wysocki,et al.  "Panning" for lymphocytes: a method for cell selection. , 1978, Proceedings of the National Academy of Sciences of the United States of America.